<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03070080</url>
  </required_header>
  <id_info>
    <org_study_id>23140000178</org_study_id>
    <nct_id>NCT03070080</nct_id>
  </id_info>
  <brief_title>Restrictive Versus Conservative Fluid Therapy in Colorectal Surgery</brief_title>
  <official_title>Restrictive Versus Conservative Fluid Therapy in Colorectal Surgery: Hemodynamics and Kidney Function Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid administration during and after surgery is an essential part of postoperative care to&#xD;
      maintain the patients' fluid and biochemical balance. Abdominal surgical procedures are&#xD;
      associated with dehydration from preoperative fasting, bowel preparation, and intra- and&#xD;
      postoperative fluid and electrolyte loss. So, perioperative fluid management has been a topic&#xD;
      of much debate over years and has intensified especially over the past several years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The controversies include the type of fluid, the timing of administration and the volume&#xD;
      administrated. Following much discussion and ongoing controversy on colloids versus&#xD;
      crystalloids and the ideal composition of the various intravenous solutions, the main focus&#xD;
      more recently has been on the volume of fluids.&#xD;
&#xD;
      Fluid therapy strategies have been developed and implemented in clinical practice over&#xD;
      several decades. The data suggest that aggressive or liberal intraoperative fluid&#xD;
      resuscitation is harmful during open abdominal operation, whereas a restrictive fluid&#xD;
      protocol has better outcomes, including fewer postoperative complications and a shorter&#xD;
      discharge time.&#xD;
&#xD;
      However, a restrictive fluid regimen has several limitations. Overly restricted or inadequate&#xD;
      fluid administration may lead to insufficient intravascular volume, tissue hypoperfusion,&#xD;
      cellular oxygenation impairment and potential organ dysfunction, prolonged recovery of bowel&#xD;
      function, and impair tissue oxygenation, which might ultimately impair wound healing&#xD;
      including healing of anastomosis.&#xD;
&#xD;
      Recently, the pleth-variability index (PVI) derived from respiratory variations in peripheral&#xD;
      perfusion index (PI) has been suggested to be an effective dynamic indicator of fluid&#xD;
      responsiveness. Different from other invasive dynamic indices, PVI provides clinicians with a&#xD;
      numerical value obtained non-invasively. PVI is calculated as [(PI max - PI min)/PI max] X&#xD;
      100, where PI max and PI min represent the maximal and the minimal value, respectively, of&#xD;
      the plethysmographic perfusion index (PI) over one respiratory cycle. PI is the ratio between&#xD;
      pulsatile and non-pulsatile infrared light absorption from the pulse oximeter, and it is&#xD;
      physiologically equivalent to the amplitude of the plethysmographic waveform. A PVI value of&#xD;
      &gt;13% before volume expansion discriminated between fluid responders and non responders with&#xD;
      81% sensitivity and 100% specificity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">May 7, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neutrophil Gelatinase-associated Lipocalin (NGAL)</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>NGAL is a renal biomarker for acute kidney injury</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>non invasive measurement of mean arterial blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>measurement of heart rate from pulse oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pleth-variability index</measure>
    <time_frame>intraoperative</time_frame>
    <description>derived from respiratory variations in peripheral perfusion index.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of bradycardia</measure>
    <time_frame>intraoperative</time_frame>
    <description>bradycardia defined as heart rate less than 50 beat per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of hypotension</measure>
    <time_frame>intraoperative</time_frame>
    <description>hypotension defined as systolic blood pressure less than 40% of baseline value</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Fluid Therapy</condition>
  <arm_group>
    <arm_group_label>restrictive group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>restrictive fluid strategy, 6 ml/kg/hour of lactated Ringer, during intraoperative period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conservative group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conservative fluid strategy, 12 ml/kg/hour of lactated Ringer, during intraoperative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>restrictive fluid strategy</intervention_name>
    <description>restrictive lactated ringers as intraoperative fluid therapy in a dose of 6ml/kg/hour</description>
    <arm_group_label>restrictive group</arm_group_label>
    <other_name>fluid therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conservative fluid strategy</intervention_name>
    <description>conservative lactated ringers as intraoperative fluid therapy in a dose of 12ml/kg/hour</description>
    <arm_group_label>conservative group</arm_group_label>
    <other_name>conservative fluid therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult patients scheduled for colorectal surgery&#xD;
&#xD;
          2. American Society of Anesthesiologists grade I-II.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. patient refusal.&#xD;
&#xD;
          2. psychiatric disorders.&#xD;
&#xD;
          3. pregnancy and lactation.&#xD;
&#xD;
          4. preexisting neurological dysfunction ( history of cerebrovascular stroke CVS)&#xD;
&#xD;
          5. Allergy to any protocol medication.&#xD;
&#xD;
          6. metastatic cancer.&#xD;
&#xD;
          7. Inflammatory bowel disease.&#xD;
&#xD;
          8. Coronary artery disease with impaired cardiac function.&#xD;
&#xD;
          9. Diabetes mellitus.&#xD;
&#xD;
         10. Renal insufficiency (serum creatinine level more than 180 Î¼mol/l).&#xD;
&#xD;
         11. unexpected intraoperative findings (small bowel obstruction, inoperable).&#xD;
&#xD;
         12. accidental massive intraoperative haemorrhage.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaled A Abdel-Rahman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assiut Iniversity hospitals</name>
      <address>
        <city>Assiut</city>
        <zip>71516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>February 28, 2017</study_first_submitted>
  <study_first_submitted_qc>February 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Khaled Abdel-Baky Abdel-Rahman</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

